[Federal Register Volume 76, Number 200 (Monday, October 17, 2011)]
[Notices]
[Pages 64088-64089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-26795]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number NIOSH-248]


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC or Advisory Committee), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Committee Public Meeting Times and Dates: (All times are Eastern 
Standard Time)

8:15 a.m.-5 p.m., November 9, 2011,
8 a.m.-12 p.m., November 10, 2011.

    Public Comment Times and Dates: (All times are Eastern Standard 
Time)

3:15 p.m.-4:15 p.m., November 9, 2011,
8:15 a.m.-9:15 a.m., November 10, 2011.


[[Page 64089]]


    Please note that the public comment period ends at the times 
indicated or following the last call for comments, whichever is 
earlier. Members of the public who want to comment must sign up at the 
meeting site, beginning at 8 a.m., each day, before the public comment 
time. Each commenter will be provided up to five minutes for comment. A 
limited number of time slots are available and will be assigned on a 
first come-first served basis. Written comments will also be accepted 
from those unable to attend the public sessions.
    Place: Jacob K. Javits Federal Building, 26 Federal Plaza, New 
York, New York, 10278.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 300 people. No additional 
seating will be allowed in the meeting space. In addition, there will 
be an audio conference setup for those who cannot attend in person. The 
conference line will accommodate up to 300 callers; therefore it is 
suggested that those interested in calling in to listen to the 
committee meeting share a line when possible.
    Security Considerations: Due to mandatory security clearance 
procedures at the Jacob K. Javits Federal Building, in-person attendees 
must present valid government-issued picture identification to security 
personnel upon entering the building and go through an airport-type 
security check. Non-U.S. citizens are encouraged to participate in the 
audio conferencing due to the extra clearance involved with in-person 
attendance. To attend in person, a non-U.S. citizen will have to call 
or send an e-mail before October 25, 2011, to the contact person in 
this Notice, and provide passport information. If clearance is 
received, you will be notified; otherwise, you will not be able to 
attend the meeting in person.
    Background: The Advisory Committee was established by Public Law 
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010, 
Title XXXIII of the Public Health Service Act), enacted on January 2, 
2011 and codified at 42 U.S.C. 300mm-300mm-61.
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
World Trade Center (WTC) Program Administrator regarding additional WTC 
Health Program eligibility criteria and potential additions to the list 
of covered WTC-related health conditions.
    Title XXXIII of the Public Health Service Act established within 
the Department of Health and Human Services (HHS), the World Trade 
Center (WTC) Health Program, to be administered by the WTC Program 
Administrator. The WTC Health Program provides: (1) Medical monitoring 
and treatment benefits to eligible emergency responders and recovery 
and cleanup workers (including those who are Federal employees) who 
responded to the September 11, 2011, terrorist attacks, and (2) initial 
health evaluation, monitoring, and treatment benefits to residents and 
other building occupants and area workers in New York City, who were 
directly impacted and adversely affected by such attacks 
(``survivors'').
    Certain specific activities of the WTC Program Administrator are 
reserved to the Secretary, HHS, to delegate at her discretion; other 
WTC Program Administrator duties not explicitly reserved to the 
Secretary, HHS, are assigned to the Director, NIOSH. The administration 
of the Advisory Committee established under Section 300mm-1(a) is left 
to the Director of NIOSH in his role as WTC Program Administrator. CDC 
and NIOSH provide funding, staffing, and administrative support 
services for the Advisory Committee. The charter was issued on May 12, 
2011, and will expire on May 12, 2013.
    Matters to be Discussed: The agenda for the Advisory Committee 
meeting includes: WTC Health Program Overview; Panel Presentations from 
WTC Responders and Survivors; Presentations from WTC Health Program 
Medical Monitoring and Treatment Programs and Health Registry; and 
discussion regarding ways and means of accomplishing the committee's 
work.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be 
submitted. The comments should be limited to two pages and submitted to 
the contact person below by October 28, 2011. Efforts will be made to 
provide the two-page written comments received by the deadline below at 
the meeting. Comments in excess of two pages will be made publicly 
available at the NIOSH docket (http://www.cdc.gov/niosh/docket/archive/docket248.html). Submissions to the docket should reference docket 
248, and be sent to the NIOSH Docket Office at:
     Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 
MS-C-34, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
     Facsimile: (513) 533-8285.
     E-mail: [email protected].
     Telephone: (513) 533-8611.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to NIOSH Docket 
248 within 30 days after the meeting. If a person making a 
comment gives his or her name, no attempt will be made to redact that 
name. NIOSH will take reasonable steps to ensure that individuals 
making public comments are aware of the fact that their comments 
(including their name, if provided) will appear in a transcript of the 
meeting posted on a public Web site. Such reasonable steps include: (a) 
A statement read at the start of the meeting stating that transcripts 
will be posted and names of speakers will not be redacted; and (b) A 
printed copy of the statement mentioned in (a) above will be displayed 
on the table where individuals sign up to make public comments. If 
individuals in making a statement reveal personal information (e.g., 
medical information) about themselves, that information will not 
usually be redacted. The CDC Freedom of Information Act coordinator 
will, however, review such revelations in accordance with the Freedom 
of Information Act and if deemed appropriate, will redact such 
information. Disclosures of information concerning third party medical 
information will be redacted.
    Contact Person for More Information: Paul J. Middendorf, PhD, 
Designated Federal Official, NIOSH, CDC, 4676 Columbia Parkway Mail 
Stop R-45, Cincinnati, Ohio 45226, telephone 1 (888) 982-4748; e-mail: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

    Dated: October 11, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-26795 Filed 10-14-11; 8:45 am]
BILLING CODE 4163-18-P